Targeting Protein-Protein Interactions to Treat Cancer-Recent Progress and Future Directions

被引：17
作者：
Garland, William [1 ]
Benezra, Robert [2 ]
Chaudhary, Jaideep [3 ]
机构：
[1] AngioGenex Inc, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] Clark Atlanta Univ, Atlanta, GA 30314 USA
来源：
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 48 | 2013年 / 48卷
关键词：
SMALL-MOLECULE ANTAGONIST; BCL-2; FAMILY; DRUG DISCOVERY; INHIBITION; ID1; MDM2; EXPRESSION; GENES; PREDICTION; APOPTOSIS;
D O I：
10.1016/B978-0-12-417150-3.00015-6
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：227 / 245
页数：19
相关论文
共 83 条
[1]   External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator [J].
Asada, S ;
Choi, Y ;
Yamada, M ;
Wang, SC ;
Hung, MC ;
Qin, J ;
Uesugi, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) :12747-12752
[2]  
Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/NCHEM.1568, 10.1038/nchem.1568]
[3]   A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer [J].
Baggstrom, Maria Q. ;
Qi, Yingwei ;
Koczywas, Marianna ;
Argiris, Athanassios ;
Johnson, Elizabeth A. ;
Millward, Michael J. ;
Murphy, Sara C. ;
Erlichman, Charles ;
Rudin, Charles M. ;
Govindan, Ramaswamy .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (10) :1757-1760
[4]   Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic [J].
Banappagari, Sashikanth ;
Corti, Miriam ;
Pincus, Seth ;
Satyanarayanajois, Seetharama .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2012, 30 (05) :594-606
[5]  
Bansal AT, 2008, CURR OPIN DRUG DISC, V11, P303
[6]  
Barillé-Nion S, 2012, ANTICANCER RES, V32, P4225
[7]   Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective [J].
Bauer, Renato A. ;
Wurst, Jacqueline M. ;
Tan, Derek S. .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (03) :308-314
[8]  
Brown S. P., 2012, ANNU REP MED CHEM, V47
[9]   Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy [J].
Castanon, Eduardo ;
Bosch-Barrera, Joaquim ;
Lopez, Ines ;
Collado, Victor ;
Moreno, Marta ;
Maria Lopez-Picazo, Jose ;
Arbea, Leire ;
Dolores Lozano, Maria ;
Calvo, Alfonso ;
Gil-Bazo, Ignacio .
JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
[10]  
Chaudhary J., 2012, [No title captured], Patent No. [8,138,356, 8138356]
123456789